These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 8556325)

  • 21. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
    Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM
    Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation.
    Obata T; Yamanaka Y; Kinemuchi H; Oreland L
    Brain Res; 2001 Jul; 906(1-2):170-5. PubMed ID: 11430875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine.
    Meissner W; Ravenscroft P; Reese R; Harnack D; Morgenstern R; Kupsch A; Klitgaard H; Bioulac B; Gross CE; Bezard E; Boraud T
    Neurobiol Dis; 2006 Jun; 22(3):586-98. PubMed ID: 16531050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
    Konieczny J; Lenda T; Czarnecka A
    Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway.
    Andrés ME; Gysling K; Bustos G
    Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1/D5, but not D2, dopamine receptor antagonists.
    Emmi A; Rajabi H; Stewart J
    J Neurosci; 1997 May; 17(10):3840-6. PubMed ID: 9133402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of involvement of glutamate-induced excitotoxicity in MPP+ toxicity in striatal dopaminergic terminals: possible involvement of ascorbate.
    Matarredona ER; Santiago M; Machado A; Cano J
    Br J Pharmacol; 1997 Jul; 121(5):1038-44. PubMed ID: 9222565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: II. Effects on extracellular monoamine, acetylcholine and adenosine levels monitored with in vivo microdialysis.
    Herrera-Marschitz M; Luthman J; Ferré S
    Psychopharmacology (Berl); 1994 Dec; 116(4):451-6. PubMed ID: 7701048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left/right nigrostriatal asymmetry in susceptibility to neurotoxic dopamine depletion with 6-hydroxydopamine in rats.
    Sullivan RM; Szechtman H
    Neurosci Lett; 1994 Mar; 170(1):83-6. PubMed ID: 8041518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nigral and striatal comparative study of the neurotoxic action of 1-methyl-4-phenylpyridinium ion: involvement of dopamine uptake system.
    Santiago M; Machado A; Cano J
    J Neurochem; 1996 Mar; 66(3):1182-90. PubMed ID: 8769882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats.
    Meissner W; Reum T; Paul G; Harnack D; Sohr R; Morgenstern R; Kupsch A
    Neurosci Lett; 2001 May; 303(3):165-8. PubMed ID: 11323111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p-Chloroamphetamine-Enhanced Neostriatal Dopamine Exocytosis in Rats Neonatally Co-lesioned with 6-OHDA and 5,7-DHT: Relevance to Parkinson's Disease.
    Kostrzewa JP; Kostrzewa RM
    Neurotox Res; 2020 Mar; 37(3):543-552. PubMed ID: 31939043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of selective dopamine depletion in medial prefrontal cortex on basal and evoked extracellular dopamine in neostriatum.
    King D; Finlay JM
    Brain Res; 1995 Jul; 685(1-2):117-28. PubMed ID: 7583236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complex I inhibitor effect on the nigral and striatal release of dopamine in the presence and absence of nomifensine.
    Santiago M; Granero L; Machado A; Cano J
    Eur J Pharmacol; 1995 Jul; 280(3):251-6. PubMed ID: 8566093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo protection of striatal dopaminergic system against 1-methyl-4-phenylpyridinium neurotoxicity by phenobarbital.
    Vizuete ML; Merino M; Cano J; Machado A
    J Neurosci Res; 1997 Aug; 49(3):301-8. PubMed ID: 9260741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of intracerebrally administered MPP+ (1-methyl-4-phenylpyridinium) in three species: microdialysis of dopamine and metabolites in mouse, rat and monkey striatum.
    Rollema H; Alexander GM; Grothusen JR; Matos FF; Castagnoli N
    Neurosci Lett; 1989 Dec; 106(3):275-81. PubMed ID: 2601882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the decrease of extracellular striatal dopamine induced by intrastriatal morphine administration.
    Piepponen TP; Mikkola JA; Ruotsalainen M; Jonker D; Ahtee L
    Br J Pharmacol; 1999 May; 127(1):268-74. PubMed ID: 10369482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study.
    Sarre S; Herregodts P; Deleu D; Devrieze A; De Klippel N; Ebinger G; Michotte Y
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):277-85. PubMed ID: 1407014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.